Serafin, Renalaiza .
HRN: 23-16-46 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2023
CEFUROXIME 500MG (TAB)
06/20/2023
06/27/2023
PO
1 Tab
BID
G1P1 1001 SP NSVD W/ Repair
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Final appropriateness: Yes
Overall appropriateness: Yes